about
Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base.Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature.High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma.Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma.A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.Nodular Lymphocyte Predominant Hodgkin Lymphoma of the Thyroid.Progressive transformation of germinal centers in children and adolescents: an intriguing cause of lymphadenopathy.Open questions in the management of nodular lymphocyte predominant hodgkin lymphoma.Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group.Autoimmune hemolytic anemia and nodular lymphocyte-predominant hodgkin lymphoma: a rare association.Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival.Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma.Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)
P2860
Q30978936-4EABFD6A-556E-4946-9FE9-BB2575EADEE1Q35297359-1DF1E036-E473-4522-98D9-42664E6AC9B2Q35544052-488C14E1-C73C-496F-BA9D-EEC72B908CE0Q36206169-45068B54-2A5A-44D9-A17B-D9FA02DD3584Q36547626-DD1D06A6-3449-4B51-BCBE-BD59D071AE96Q37504018-B72D1C7A-C622-4D7C-95F8-BFEBBB3AE896Q38019441-FBB044FB-691E-4085-ABCD-0E595AEEDAEFQ38632629-396EFD2F-67D4-4899-BFDC-C8DE14248BE5Q38927069-CD96686F-C08A-434A-AABE-C39D7735C910Q39904031-EEDA4E1D-F511-4B35-883C-CF1F5D0F3CA2Q40246473-EC85148F-B864-4A0F-B334-E09CE1B58900Q45283058-70F557A7-4E13-4CAE-9A63-2EF3483FE93EQ53081684-A5D9CBC4-AA12-482D-B068-EC70D0E7B9B4Q53241467-BF2F2950-6763-41BC-A02D-77B7934BE641Q57225717-A9824CAA-0F73-4278-A395-8307D99C6A5D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nodular lymphocyte predominant Hodgkin lymphoma.
@en
Nodular lymphocyte predominant Hodgkin lymphoma.
@nl
type
label
Nodular lymphocyte predominant Hodgkin lymphoma.
@en
Nodular lymphocyte predominant Hodgkin lymphoma.
@nl
prefLabel
Nodular lymphocyte predominant Hodgkin lymphoma.
@en
Nodular lymphocyte predominant Hodgkin lymphoma.
@nl
P1433
P1476
Nodular lymphocyte predominant Hodgkin lymphoma.
@en
P2093
Alfred Ian Lee
Ann S LaCasce
P304
P356
10.1634/THEONCOLOGIST.2009-0099
P577
2009-07-15T00:00:00Z